InsidersTradesSigma
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by COMMODORE CAPITAL LP. Insider active across 1 companies, notably Satsuma Pharmaceuticals, Inc.. Aggregated, 22 disclosures have been recorded. Total volume traded: €3.2m. The latest transaction was filed on 24 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations22 total
€14,0842,922 shares@ €4.820.9% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001545·
Ideal exit: 21 Aug 2022 (T+270)
€14,0842,922 shares@ €4.820.4% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001545:0·
Ideal exit: 21 Aug 2022 (T+270)
€15,4323,225 shares@ €4.78521.0% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001523·
Ideal exit: 16 Aug 2022 (T+270)
€15,4323,225 shares@ €4.78520.5% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001523:0·
Ideal exit: 16 Aug 2022 (T+270)
€48,5439,622 shares@ €5.0453.0% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001471·
Ideal exit: 7 Aug 2022 (T+270)
€48,5439,622 shares@ €5.0451.5% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001471:0·
Ideal exit: 7 Aug 2022 (T+270)
€2,900560 shares@ €5.17770.2% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001460·
Ideal exit: 5 Aug 2022 (T+270)
€2,900560 shares@ €5.17770.1% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001460:0·
Ideal exit: 5 Aug 2022 (T+270)
€7,0871,400 shares@ €5.06210.4% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001450·
Ideal exit: 1 Aug 2022 (T+270)
€7,0871,400 shares@ €5.06210.2% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001450:0·
Ideal exit: 1 Aug 2022 (T+270)
€43,1778,880 shares@ €4.86222.7% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001430·
Ideal exit: 30 Jul 2022 (T+270)
€43,1778,880 shares@ €4.86221.4% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001430:0·
Ideal exit: 30 Jul 2022 (T+270)
€218,21844,651 shares@ €4.887213.7% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001420·
Ideal exit: 26 Jul 2022 (T+270)
€218,21844,651 shares@ €4.88726.8% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001420:0·
Ideal exit: 26 Jul 2022 (T+270)
€185,96139,581 shares@ €4.698211.7% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001408·
Ideal exit: 24 Jul 2022 (T+270)
€185,96139,581 shares@ €4.69825.8% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001408:0·
Ideal exit: 24 Jul 2022 (T+270)
€152,43132,816 shares@ €4.6459.6% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001391·
Ideal exit: 18 Jul 2022 (T+270)
€152,43132,816 shares@ €4.6454.8% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001391:0·
Ideal exit: 18 Jul 2022 (T+270)
€381,73387,580 shares@ €4.358723.9% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001384·
Ideal exit: 16 Jul 2022 (T+270)
€381,73387,580 shares@ €4.358712.0% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001384:0·
Ideal exit: 16 Jul 2022 (T+270)
€525,022126,000 shares@ €4.166832.9% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001373·
Ideal exit: 12 Jul 2022 (T+270)
€525,022126,000 shares@ €4.166816.5% of flow
Common Stock, par value $0.0001 per share
SEC:0000905718-21-001373:0·
Ideal exit: 12 Jul 2022 (T+270)
22 of 22 declarations
About COMMODORE CAPITAL LP
COMMODORE CAPITAL LP is an investor in Satsuma Pharmaceuticals, Inc.
